Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene

about

Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene

Item

http://www.wikidata.org/entity/Q58573280

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Metformin reverses the resista ...... that knocks down the Nrf2 gene

@en

Metformin reverses the resista ...... that knocks down the Nrf2 gene

@nl

type

Item

label

Metformin reverses the resista ...... that knocks down the Nrf2 gene

@en

Metformin reverses the resista ...... that knocks down the Nrf2 gene

@nl

prefLabel

Metformin reverses the resista ...... that knocks down the Nrf2 gene

@en

Metformin reverses the resista ...... that knocks down the Nrf2 gene

@nl

P1476

Metformin reverses the resista ...... that knocks down the Nrf2 gene

@en

P2093

Jiacui Zhang

http://www.w3.org/2001/XMLSchema#string

Jing Liu

http://www.w3.org/2001/XMLSchema#string

Keping Jiao

http://www.w3.org/2001/XMLSchema#string

Yu Xia

http://www.w3.org/2001/XMLSchema#string

P2860

Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor

The regulation of AMP-activated protein kinase by phosphorylation

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Role of Nrf1 in antioxidant response element-mediated gene expression and beyond

Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Repurposing of metformin and aspirin by targeting AMPK-mTOR and inflammation for pancreatic cancer prevention and treatment

Emerging roles of Nrf2 signal in non-small cell lung cancer

Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

P304

6071-6080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.9382

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30333878

http://www.w3.org/2001/XMLSchema#string

P921

metformin

cancer research

adenocarcinoma

P932

6176423

http://www.w3.org/2001/XMLSchema#string